Skip to main content
    S

    Sana Biotechnology Inc (SANA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.88
    +0.00 (+0.00%)

    Market Cap: $563.31M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Sana Biotechnology Inc (SANA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sana Biotechnology (SANA) has a market cap of $563.31M and an enterprise value of $603.38M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 17.85% from a year earlier.

    Total Valuation

    Enterprise value is 7.11% above the market cap, as debt exceeds cash.

    Market Cap$563.31M
    Enterprise Value$603.38M
    Latest price (Nov 17, 2026)$1.88

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 3.83% in the quarter ended Sep 30, 2026 and grew 14.20% a year over 2 years.

    Shares Outstanding307.00M
    Shares Change (YoY)+17.85%
    Shares Change (QoQ)+3.83%
    Share Count Growth (2Y CAGR)+14.20%

    Price Statistics

    The stock is down 52.88% over 52 weeks and trades 29.06% below its 50-day average.

    Beta (1Y)2.17
    52-Week Change-52.88%
    1-Month Change-18.26%
    3-Month Change-54.15%
    6-Month Change-38.56%
    5-Year Change-87.61%
    Total Return (1Y)-52.88%
    Total Return (3Y CAGR)-23.50%
    Total Return (5Y CAGR)-38.27%
    Return vs SPY (1Y)-58.30%
    Max Drawdown (1Y)-63.71%
    Max Drawdown (3Y)-88.11%
    Sharpe Ratio (1Y)-0.85
    Correlation with SPY (1Y)0.40
    50-Day Average$2.65
    200-Day Average$3.25
    52-Week Range$1.86 to $5.49
    RSI (14 Days)29.8
    Average Volume (20 Days)2.71M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.77x current liabilities, and total debt is 0.45x shareholder equity.

    Current Ratio1.77x
    Quick Ratio1.77x
    Debt / Equity0.45x

    Returns and Efficiency

    Return on invested capital is -46.80% over the last 12 months, against a 5-year average of -74.62%.

    Return on Equity (ROE)-82.76%
    Return on Assets (ROA)-39.69%
    Return on Invested Capital (ROIC)-46.80%
    ROE (5Y Average)-91.92%
    ROA (5Y Average)-45.24%
    ROIC (5Y Average)-74.62%

    Scores

    SANA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$3.05M
    Operating Income-$156.73M
    Pretax Income-$151.57M
    Net Income-$149.27M
    EBITDA-$144.29M
    Reported EPS (TTM)-$0.57

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 47.95% of the $376.13M in total assets.

    Cash and Equivalents$41.10M
    Total Debt$81.17M
    Net Debt$40.07M
    Net Debt Per Share$0.13
    Working Capital$57.43M
    Shareholder Equity$180.36M
    Book Value Per Share$0.59
    Tangible Book Value-$19.46M
    Total Assets$376.13M
    Total Liabilities$195.76M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.57M of capital spending, operating cash flow left -$145.13M of free cash flow.

    Operating Cash Flow-$141.56M
    Capital Expenditures$3.57M
    Free Cash Flow-$145.13M
    FCF Per Share-$0.48
    Depreciation and Amortization$10.65M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    SANA does not pay a dividend. Its free cash flow yield is -25.15%.

    FCF Yield-25.15%
    Buyback Yield-19.30%
    Shareholder Yield-19.30%

    Peer Position

    Against 3 similar companies, SANA has the 3rd highest ROIC.

    ROIC-46.80% vs -38.29% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -97.79% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SANA

    What is SANA's market cap?

    Sana Biotechnology has a market cap of $563.31M. Its enterprise value, which adds debt and subtracts cash, is $603.38M.

    How many shares of SANA are outstanding?

    Sana Biotechnology has 307.00M shares outstanding. The count is up 17.85% from a year earlier.

    Does SANA pay a dividend?

    No. Sana Biotechnology does not pay a dividend.

    How much debt does SANA have?

    Sana Biotechnology has $81.17M of total debt and $41.10M of cash and equivalents, a net debt position of $40.07M.